
Sign up to save your podcasts
Or


Aleksandra Rachitskaya, MD, moderates a panel comprised of Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD, to review a study from the DRCR Retina Network that compared intravitreal aflibercept (Eylea, Regeneron) to vitrectomy with panretinal photocoagulation for the treatment of vitreous hemorrhage secondary to proliferative diabetic retinopathy. The group summarizes the study and weighs how its findings could affect clinical practice.
This editorially independent podcast is supported with advertising.
 By Retina Today
By Retina Today4.4
1717 ratings
Aleksandra Rachitskaya, MD, moderates a panel comprised of Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD, to review a study from the DRCR Retina Network that compared intravitreal aflibercept (Eylea, Regeneron) to vitrectomy with panretinal photocoagulation for the treatment of vitreous hemorrhage secondary to proliferative diabetic retinopathy. The group summarizes the study and weighs how its findings could affect clinical practice.
This editorially independent podcast is supported with advertising.

43 Listeners

2,442 Listeners

5 Listeners

7,070 Listeners

11 Listeners

21 Listeners

52 Listeners

10 Listeners

18 Listeners

0 Listeners

1 Listeners

19 Listeners

0 Listeners

1,291 Listeners

0 Listeners